£1.8 million investment to stop MS
MS research on treatments and care
Our new projects cover a wide range of research areas, from finding new treatments to improving care and services.
They include supporting Professor Olga Ciccarelli and her team to develop a computer algorithm that can predict which treatments will work best for different people. It will use information about their lifestyle, genes and medical records to make individual recommendations.
This is an exciting step towards “personalised medicine”, which means we'll be able to prescribe the right medication for the right person at the right time.
Progress on MS progression
Since we were founded in 1953 we’ve made steady progress in finding treatments for relapsing MS and improving care and services for everyone affected by MS. But there's still only one licensed treatment for progressive MS.
So we’re supporting more research than ever into progressive MS through our 2018 grant round. This includes Dr Don Mahad’s project to discover the biological basis of fatigue in progressive MS.
We’re also funding Professor Gabriele DeLuca at the University of Oxford to investigate the causes of nerve damage in progressive MS.
Shaped by people living with MS
Our research programme is shaped by our Research Network – a group of people living with MS – who make sure every project we fund is driven by the priorities of the MS community.
Our grant review panels are made up of MS researchers, clinical experts and members of the Research Network.
A huge impact
Dr Susan Kohlhaas, our Director of Research, said:
“We’re driving research into more and better treatments all the time, and are proud to be investing almost £2 million into these exciting new projects. Led by dedicated MS researchers across the UK, they have the potential to have a huge impact on the field of MS research. And we believe they can ultimately help us stop MS.”